sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has disclosed its current positions and dealings in Spire Healthcare Group plc's securities pursuant to Rule 8.3 of the Takeover Code. As of September 30, 2025, Vanguard held a 3.58% interest in Spire Healthcare's 1p ordinary shares, totaling 14,407,467 shares. This disclosure indicates a significant investment stake by Vanguard in Spire Healthcare.
The announcement also confirms that Vanguard sold 47,117 of Spire's ordinary shares at a price of 2.49 GBP each. No additional transactions involving cash-settled or stock-settled derivatives have been reported. Furthermore, the disclosure reveals no agreements or arrangements relating to securities, options, or derivatives.
This report provides key insights into Vanguard's strategic investments in the healthcare sector, showcasing its role as a substantial shareholder in Spire Healthcare.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.